ClearPoint Neuro, Inc. - SIC # 3844 - X-RAY APPARATUS AND TUBES AND RELATED IRRADIATION APPARATUS

Ticker Exchange SIC # Website Latest Ticker
CLPT Nasdaq 3844 www.clearpointneuro.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ClearPoint Neuro, Inc.

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain - Nov 13th, 2024 11:15 pm
The ClearPoint Neuro, Inc. (NASDAQ:CLPT) Third-Quarter Results Are Out And Analysts Have Published New Forecasts - Nov 10th, 2024 1:02 pm
ClearPoint Neuro Reports Third Quarter 2024 Results - Nov 7th, 2024 9:05 pm
Those who invested in ClearPoint Neuro (NASDAQ:CLPT) five years ago are up 213% - Nov 6th, 2024 10:34 am
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024 - Oct 31st, 2024 8:05 pm
ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024 - Oct 17th, 2024 8:05 pm
ClearPoint Neuro Announces Early Repayment of $10 Million Note - Aug 26th, 2024 8:05 pm
ClearPoint Neuro Reports Second Quarter 2024 Results - Aug 7th, 2024 8:05 pm
ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024 - Jul 17th, 2024 8:05 pm
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial - Jun 20th, 2024 12:45 pm
Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons - Jun 20th, 2024 12:30 pm
ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System - Jun 1st, 2024 1:00 pm
ClearPoint Neuro Inc (CLPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth ... - May 8th, 2024 7:53 am
ClearPoint Neuro Reports First Quarter 2024 Results - May 7th, 2024 8:05 pm
ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore - May 2nd, 2024 8:05 pm
ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory - Apr 29th, 2024 12:00 pm
ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System - Apr 24th, 2024 8:05 pm
ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024 - Apr 23rd, 2024 8:05 pm
Is There Now An Opportunity In ClearPoint Neuro, Inc. (NASDAQ:CLPT)? - Apr 19th, 2024 11:31 am
ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations - Apr 16th, 2024 8:05 pm